ATS 2018
Efficacy, Safety of Dupilumab in Corticosteroid-Dependent Severe Asthma
Subcutaneous dupilumab significantly reduced the use of oral corticosteroids in patients with corticosteroid-dependent severe asthma.
Your search for oral corticosteroids returned 3 results
ATS 2018
Lung Function in Severe Asthma Improved With Benralizumab
Peak expiratory flow increases were greater with benralizumab than placebo in patients with severe eosinophilic asthma.
ATS 2019
PONENTE Trial May Provide Guidance for OCS Tapering in Asthma
Benralizumab has been found to be associated with a reduction in oral corticosteroid (OCS) use while maintaining asthma control for patients with OCS-dependent severe asthma.
